Startups & growth Analysis
Paralos Bioscience turns research designs into phage tools while pursuing drug delivery
Paralos Bioscience offers custom phage materials to research labs and is separately developing a preclinical drug-delivery platform.
PB
Paralos Bioscience offers custom phage-display research materials and develops a preclinical drug-delivery platform.
Overview
Paralos Bioscience offers custom M13 phage-display constructs and defined libraries to research teams that supply candidate sequences. Customers can order separately prepared constructs or request a quote for a pooled library, then arrange their own screening and validation.
The company also develops a separate phage-based drug-delivery platform. UCLA’s Magnify incubator describes its lead therapeutic focus as drug-resistant infections and its stage as preclinical.
- Legal company name
- Paralos Bioscience Inc.
Company timeline
Timeline supplied to MoneyMakers.
Summer accelerator participation
UCLA featured Paralos Bioscience in its 2026 startup accelerator showcase.
Loading profile details…
Industries
- Industry category
- Healthcare & Life Sciences
- Specific industry
- Biotech Research
Classification sources and history
Biotech Research · Business involvement
As of 2026-11-09
Loading recent changes…
Sources & editorial review
(5)
- Paralos Bioscience homepage
- Paralos custom phage-display services
- Paralos phage-display FAQ
- Paralos therapeutics and science
- UCLA Magnify: Paralos Bioscience
Editorial profile by MoneyMakers. Sources reviewed .
